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Abstract
Patients with spontaneous lens dislocation and glaucoma can be challenging to manage. We present a forty-six
year old Caucasian lady who was referred with bilateral high intraocular pressure, and was subsequently diagnosed
with glaucoma in association with lens dislocation and Marfan syndrome. Baerveldt glaucoma drainage device
tubes were inserted in both eyes due to poor response to medical therapy. However, this was complicated by
recurrent vitreous occlusion of both glaucoma drainage tubes requiring further multiple surgical interventions.
There have not been any further recurrences of vitreous incarceration or posterior segment complications since,
but the patient remains under close follow-up.
Case presentation
A 46-year old Caucasian female was originally referred
to the Eye Casualty department by the community opto-
metrist because of bilateral raised intraocular pressures
(IOPs) in the thirties. At Eye Casualty, she was addition-
ally noted to be aphakic. She was started on topical
Cosopt bd to both eyes, and was referred on to the
Glaucoma Clinic. Interestingly, she had not been
informed by the optometrist that she was aphakic.
At her first presentation to the Glaucoma Clinic in
May 2007, her IOPs had reduced to 22 mmHg in the
right and 20 mmHg in the left. Her best-corrected visual
acuity (BCVA) was 6/12 N5 right and 6/36 N24 left. She
was bilaterally aphakic. Gonioscopy showed open angles.
The corneas were clear with no endothelial pigmenta-
tion, and the irides did not have any transillumination
defects. The anterior chambers (AC) were deep and
quiet, with no sign of any vitreous prolapse. The optic
d i s c sw e r eb o t hp a l ea n dc u p p e d ,w i t hac u p - d i s cr a t i o
of 0.8. Both lenses were dislocated into the vitreous cav-
ity. The rest of the dilated fundal examination was nor-
mal; no vitritis or retinal breaks were detected. The
dislocated lenses and absence of retinal breaks were
confirmed on ocular ultrasound (Figure 1). Timolol
caused palpitations, and was discontinued.
She was a non-smoker, was generally fit and well, and
had 2 children. She had previous hysterectomy, mild
asthma and osteoporosis, and was on hormone replace-
ment therapy. Apart from left amblyopia, she had no
other ocular history of note, including trauma or sur-
gery. There was no family history of any inherited ocular
conditions. Her father was a type 2 diabetic with an
undiagnosed ‘eye problem’,a n dh a dd i e du n e x p e c t e d l y
from a myocardial infarction in his forties.
In view of her apparent bilateral spontaneous lens dis-
location, a general physical examination was performed.
She was 170 cm tall, with an arm span to height ratio of
more than 1.05. She also had a high arched palate and
joint hypermobility. No heart murmurs were heard on
auscultation. Echocardiography revealed a normal aortic
arch, but a dilated ascending aorta and mild aortic
regurgitation. Based on the ocular, skeletal and cardiac
findings, the patient was diagnosed with Marfan syn-
drome. Subsequently, her son was also diagnosed with
Marfan syndrome. They both remain under current
review by the cardiologists.
Despite maximal topical medical therapy (latanoprost
0.004%, dorzolamide 2% and brimonidine 0.2%), her
IOPs remained high at 29 mmHg right and 41 mmHg
left. Additional IOP control was only achieved with oral
acetazolamide. Seven months after her first presentation,
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nage device (GDD) was brought up. The risks and bene-
fits of surgery to her left eye were discussed at length.
In addition to the ocular risks, the anaesthetic risks
associated with Marfan syndrome were also discussed.
She agreed, and was listed for left Baerveldt implant
insertion under general anaesthetic.
The 350 mm
2 Baerveldt device implantation at the
superotemporal quadrant of the left eye proceeded routi-
nely without any complications. As vitreous was not pre-
sent in the AC nor was it at the pupillary plane, anterior
vitrectomy was not performed at the same setting. Two
weeks postoperatively, her IOPs were 42 mmHg right and
39 mmHg left. Her left pupil was peaked, with vitreous
plugging the tube opening. Vitreolysis was successfully
performed with Nd:YAG laser. Unfortunately, 2 weeks
later, vitreous had occluded the left Baerveldt tube again.
Laser vitreolysis was repeated successfully. A vitreo-retinal
consultation was sought, and it was felt that the risk of ret-
inal detachment from pars plana vitrectomy (PPV) out-
weighed the benefits, especially when the incarceration
had been successfully treated with laser vitreolysis.
Unfortunately, she developed vitreous incarceration
for the third time. By then both IOPs had become
uncontrollable (34 mmHg right and 31 mmHg left)
despite maximal topical and systemic medical therapy. It
was decided that surgery was required for both eyes -
GDD for the right, and anterior vitrectomy for the left.
Two weeks later, a 350 mm
2 Baerveldt implant was
placed in her right eye at the superotemporal quadrant,
w i t h o u ta n yc o m p l i c a t i o n s .A g a i n ,n ov i t r e o u sw a s
detected in the AC intraoperatively, and anterior vitrect-
omy was therefore not performed. For the left eye, ante-
rior vitrectomy was performed with a 25-gauge
vitrectomy probe via a corneal approach. At the end of
surgery, no vitreous could be seen in the AC, and flush-
i n go ft h eB a e r v e l d tt u b er e s u l t e di na ni n c r e a s ei nt h e
height of the conjunctival bleb.
One month postoperatively, vitreous had plugged the
left tube for the fourth time. A second more extensive
anterior vitrectomy was therefore performed with an AC
maintainer and a 25-gauge vitrectomy probe via the pars
plana. The same evening after her second left anterior
vitrectomy, she became symptomatic with right eye pain
Figure 1 Ocular ultrasound of the left eye demonstrating the dislocated lens in the vitreous cavity. Ocular ultrasound of the left eye at
presentation demonstrating the dislocated lens (heterogeneous hyperechogenic oval-shaped mass) within the vitreous cavity (hypoechogenic).
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with associated with vitreous plugging of the tube. The
next day, she underwent right anterior vitrectomy with
a pars plana approach. Unfortunately, six weeks later,
vitreous was found to be plugging the right tube for the
second time, necessitating a second right pars plana
anterior vitrectomy.
Despite this, her right pupil became peaked 10 days
later with an IOP of 22 mmHg, although no obvious
vitreous strands could be seen in the AC. A repeat
vitreo-retinal consultation was sought, and she subse-
quently underwent right PPV and heavy liquid-assisted
lens removal via a scleral tunnel section. At the last
clinic visit (10 weeks after her PPV), her IOPs were 11
mmHg right (with brimonidine 0.2% bd and dorzola-
mide 2% bd) and 15 mmHg left (with brimonidine 0.2%
bd, dorzolamide 2% bd and travoprost 0.004% nocte). So
far, there have been no recurrences of vitreous incar-
ceration to either tube (Figure 2), and no posterior seg-
ment complications have occurred.
Discussion
Marfan syndrome is an inherited mixed connective tis-
sue disorder which usually presents as a constellation of
signs and symptoms involving 2 or more organ systems
such as skeletal, joints, dermatological, dural sac, lungs,
ocular or cardiac malformations. It is an autosomal
dominant condition, and is due to a mutation in the
fibrillin-1 gene located on chromosome 15q21. It is the
commonest inherited multi-system disorder of connec-
tive tissue. Approximately 80% of Marfan syndrome
cases are inherited, while the remainder are due to de
novo mutations. Despite advancements in genetic test-
ing, the diagnosis of Marfan syndrome is still dependent
on clinical features (Table 1), as based on the modified
Ghent criteria listed below:[1]
1. A first-degree relative with confirmed Marfan syn-
drome, major criteria in one organ system, and
involvement of a second organ system; or
2. A fibrillin-1 gene mutation known to cause Mar-
fan syndrome, major criteria in one organ system,
and involvement of a second organ system; or
3. Major criteria in two organ systems, and involve-
ment of a third organ system
Our case report illustrates the difficulties and chal-
lenges that can arise when managing a Marfan syn-
drome patient with lens dislocation and glaucoma.
Firstly, it was difficult to ascertain the mechanism or
Figure 2 Colour photograph of the left eye showing the Baerveldt implant tube with a round pupil. Colour photograph of the left eye
one week following her second anterior vitrectomy (via the pars plana) - the Baerveldt implant tube looked patent, the pupil was round and
there was no vitreous in the anterior chamber.
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kia can be very difficult to control, and this was cer-
tainly the case for our patient. Thirdly, lens dislocation
and aphakia are significant risk factors for retinal
detachment in Marfan syndrome. Any surgical proce-
dure involving or affecting the vitreous will considerably
increase this risk.
There is a general consensus that trabeculectomy in
aphakia would be less successful than in phakic eyes
[2,3]. There have been 2 randomised trials comparing
MMC-augmented trabeculectomy with GDDs (one with
Ahmed glaucoma implants, and the other with 350 mm
2
Baerveldt implants) [4,5], both demonstrating no differ-
ence in IOP control at one year. However, these 2 trials
did not include glaucoma patients with aphakia. We
eventually proceeded with 350 mm
2 Baerveldt device
implantation as our primary surgical procedure on the
basis that trabeculectomy would have a higher rate of
failure because of our patient’s aphakic status and prob-
able tendency towards trabeculectomy bleb scarring due
to her relatively young age. We acknowledge that GDD
implantation is not without its complications, which
include hypotony, endophthalmitis, tube exposure, and
ocular motility problems.
I tm a yb ep o s s i b l et h a tc o m b i n i n gt h eB a e r v e l d t
implant surgery with adequate core anterior vitrectomy
or PPV during the primary surgery for our patient
would have reduced the risk of vitreous incarceration
into the tube. Desatnik et al reported that vitreous
incarceration in implant tubes occurred despite 6 of the
series of 8 eyes having previous anterior vitrectomy, and
concluded that anterior vitrectomy was insufficient in
preventing vitreous occlusi o n[ 6 ] ,H o w e v e r ,i nt h e s e
eyes, the implant was either inserted into the vitreous
cavity, or the vitreous was already present in the AC
during implant surgery (i.e. insufficient anterior
Table 1 Major Modified Ghent criteria for Marfan syndrome
System Major features Minor features Requirement
Skeletal Pectus carinatum
Pectus excavatum needing
surgery
Arm span to height ratio
>1.05
Wrist (Walker) and thumb
(Steinberg) signs
Scoliosis >20° or
spondylolisthesis
Reduced elbow extension
<170°
Pes planus
Protrusio acetabuli
Pectus excavatum
Thoracic lordosis
Scoliosis <20°
Joint hypermobility
Highly arched palate
Dental crowding
Typical facies (dolichocephaly, malar hypoplasia, enophthalmos, retrognathia,
downward slanting
palpebral fissures)
2 major features;
Or, 1 major and 2 minor
features
Ocular Ectopia lentis Flat cornea
Axial length >23.5 mm
Hypoplastic iris or
ciliary muscle
causing reduced miosis
Nuclear sclerosis under
the age of 50
Glaucoma under the age of 50
Retinal detachment
Major feature;
Or, 2 minor features
Cardiovascular Dilatation of the ascending
aorta
involving the sinuses of
Valsalva
Dissection of the ascending
aorta
Mitral valve prolapse
Dilatation of the main
pulmonary artery under
the age of 40
Calcification of the mitral annulus
under the age of 40
Dilatation or dissection of
the thoracic or
abdominal aorta under
the age of 50
1 minor feature
Pulmonary None Spontaneous pneumothorax
Apical blebs
1 minor feature
Skin None Striae atrophicae
Recurrent or incisional hernia
1 minor feature
Dura Dural ectasia - enlargement
of the dural sac in the
lumbosacral
region (CT or MRI)
Major feature
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combined PPV with GDD implantation to be successful
in controlling IOP in refractory glaucoma, including
patients with aphakic glaucoma [7-9]. However, this
increases the risk of posterior segment complications,
such as retinal detachment, epiretinal membrane, and
cystoid macular oedema. We did not perform PPV dur-
ing the primary procedure because at that time, it was
felt that it would have significantly increased the risk of
retinal detachment, which may in turn be complicated
by severe proliferative vitreoretinopathy or giant retinal
tear with consequent poor visual outcome. This was
particularly important for her non-amblyopic eye.
Pars plana vitrectomy, if performed properly, would
ensure that vitreous would not become incarcerated in
the Baerveldt tube opening, and would also remove a
potential cause for intraocular inflammation and phaco-
lytic glaucoma. In a series of 8 eyes of 8 patients with
vitreous incarceration in the Baerveldt implant, 6 were
successfully treated with PPV and 1 with Nd:YAG
vitreolysis alone [6]. Cyclodiode laser ciliary ablation is
also another option, with a moderate success rate (48%)
in glaucoma in aphakia [10]. However, with the consid-
erable potential complications of hypotony, phthisis
bulbi, retinal detachment, and macular oedema, it will
only be realistically considered as a last resort for our
patient, or if no useful visual function remains. Our
patient eventually required multiple anterior vitrec-
tomies to both eyes and full PPV to the right. Looking
back in retrospect, it could be argued that PPV, or at
least anterior vitrectomy, should also have been per-
formed during the primary surgery.
Conclusion
This report illustrates the difficulties in balancing poten-
tial benefits against potential risks of surgical interven-
tions, especially for the non-amblyopic eye. A full PPV
for our patient could potentially result in devastating
posterior segment complications, causing our patient to
be significantly worse off compared to before surgery. It
is also vital to remember that Marfan syndrome is a sys-
temic condition, where aortic dissection is an important
but preventable cause of mortality. The importance of a
general medical and systemic examination in a patient
with apparent spontaneous lens dislocation to detect
any associated systemic disorder cannot be emphasised
enough.
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